S&P 500   5,089.55 (+0.05%)
DOW   39,158.10 (+0.23%)
QQQ   437.95 (-0.03%)
AAPL   182.78 (-0.86%)
MSFT   409.63 (-0.49%)
META   486.96 (+0.17%)
GOOGL   143.94 (-0.10%)
AMZN   174.68 (+0.06%)
TSLA   194.75 (-1.35%)
NVDA   797.27 (+1.51%)
NIO   5.43 (-7.18%)
AMD   176.10 (-3.17%)
BABA   76.33 (+0.28%)
T   16.80 (+1.27%)
F   12.23 (+0.91%)
MU   85.67 (-0.28%)
CGC   3.26 (-3.26%)
GE   153.60 (+1.27%)
DIS   107.00 (-0.59%)
AMC   4.47 (+1.13%)
PFE   28.01 (+1.67%)
PYPL   59.26 (+1.56%)
XOM   103.57 (-1.14%)
S&P 500   5,089.55 (+0.05%)
DOW   39,158.10 (+0.23%)
QQQ   437.95 (-0.03%)
AAPL   182.78 (-0.86%)
MSFT   409.63 (-0.49%)
META   486.96 (+0.17%)
GOOGL   143.94 (-0.10%)
AMZN   174.68 (+0.06%)
TSLA   194.75 (-1.35%)
NVDA   797.27 (+1.51%)
NIO   5.43 (-7.18%)
AMD   176.10 (-3.17%)
BABA   76.33 (+0.28%)
T   16.80 (+1.27%)
F   12.23 (+0.91%)
MU   85.67 (-0.28%)
CGC   3.26 (-3.26%)
GE   153.60 (+1.27%)
DIS   107.00 (-0.59%)
AMC   4.47 (+1.13%)
PFE   28.01 (+1.67%)
PYPL   59.26 (+1.56%)
XOM   103.57 (-1.14%)
S&P 500   5,089.55 (+0.05%)
DOW   39,158.10 (+0.23%)
QQQ   437.95 (-0.03%)
AAPL   182.78 (-0.86%)
MSFT   409.63 (-0.49%)
META   486.96 (+0.17%)
GOOGL   143.94 (-0.10%)
AMZN   174.68 (+0.06%)
TSLA   194.75 (-1.35%)
NVDA   797.27 (+1.51%)
NIO   5.43 (-7.18%)
AMD   176.10 (-3.17%)
BABA   76.33 (+0.28%)
T   16.80 (+1.27%)
F   12.23 (+0.91%)
MU   85.67 (-0.28%)
CGC   3.26 (-3.26%)
GE   153.60 (+1.27%)
DIS   107.00 (-0.59%)
AMC   4.47 (+1.13%)
PFE   28.01 (+1.67%)
PYPL   59.26 (+1.56%)
XOM   103.57 (-1.14%)
S&P 500   5,089.55 (+0.05%)
DOW   39,158.10 (+0.23%)
QQQ   437.95 (-0.03%)
AAPL   182.78 (-0.86%)
MSFT   409.63 (-0.49%)
META   486.96 (+0.17%)
GOOGL   143.94 (-0.10%)
AMZN   174.68 (+0.06%)
TSLA   194.75 (-1.35%)
NVDA   797.27 (+1.51%)
NIO   5.43 (-7.18%)
AMD   176.10 (-3.17%)
BABA   76.33 (+0.28%)
T   16.80 (+1.27%)
F   12.23 (+0.91%)
MU   85.67 (-0.28%)
CGC   3.26 (-3.26%)
GE   153.60 (+1.27%)
DIS   107.00 (-0.59%)
AMC   4.47 (+1.13%)
PFE   28.01 (+1.67%)
PYPL   59.26 (+1.56%)
XOM   103.57 (-1.14%)

Roivant Sciences (ROIVW) SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.

Recent Roivant Sciences SEC Filings

DateFilerForm TypeView
02/22/2024
8:01 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
8:01 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
8:01 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:46 PM
Ramaswamy Vivek (Filed by)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form SC 13G/A
02/14/2024
9:20 AM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/14/2024
5:51 AM
Dexcel Pharma Technologies Ltd. (Filed by)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form SC 13G/A
02/13/2024
4:26 PM
Ramaswamy Vivek (Filed by)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form SC 13G/A
02/13/2024
6:15 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2024
6:05 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:00 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
4:24 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13G/A
01/30/2024
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
Oren Ilan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
Epperly Melissa B, (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
Fitzgerald Meghan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:00 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
8:00 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
8:00 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Sukhatme Mayukh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
8:00 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
6:00 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
6:00 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
6:00 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
4:05 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:31 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K/A
12/14/2023
8:17 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
8:31 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
8:30 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
6:54 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
8:30 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
7:06 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
8:30 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
6:06 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:16 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
8:39 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
8:30 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/26/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
8:30 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
8:32 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2023
8:32 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2023
8:32 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2023
5:00 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
8:30 PM
Fitzgerald Meghan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
8:30 PM
Epperly Melissa B, (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
8:30 PM
Oren Ilan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
8:30 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
8:40 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2023
11:15 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form EFFECT
10/06/2023
3:30 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 424B5
10/04/2023
8:30 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:15 PM
Immunovant, Inc. (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:19 PM
Immunovant, Inc. (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences (Filed by)
Form SC 13D/A
10/04/2023
3:27 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
8:30 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
7:55 PM
Gold Daniel Allen (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
8:00 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
SB INVESTMENT ADVISERS LTD (0001731509) (Reporting)
SoftBank Vision Fund L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
8:05 PM
MANCHESTER KEITH S (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
7:43 PM
QVT Financial LP (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:27 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/29/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
8:30 PM
Pulik Richard (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/29/2023
8:30 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
8:30 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Sukhatme Mayukh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
8:30 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
4:24 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/29/2023
3:30 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
8:30 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/28/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/28/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/28/2023
8:03 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
SVF Investments Ltd (0001716729) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/28/2023
7:23 PM
QVT Financial LP (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2023
3:59 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
8:30 PM
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
4:25 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 424B5
09/26/2023
7:00 AM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
8:30 PM
Gline Matthew (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/21/2023
8:30 PM
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/21/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Subject)
Roivant Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
8:31 PM
Oren Ilan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
8:33 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
3:30 PM
Roivant Sciences Ltd. (Filer)
Roivant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:30 PM
Gold Daniel Allen (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:30 PM
MANCHESTER KEITH S (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:31 PM
Oren Ilan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:31 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:31 PM
Fitzgerald Meghan (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:31 PM
Epperly Melissa B, (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
8:30 PM
Kumar Rakhi (Reporting)
Roivant Sciences Ltd. (Issuer)
Roivant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ROIVW) was last updated on 2/23/2024 by MarketBeat.com Staff